Assessing clinical cure of empirical piperacillin/tazobactam for ESBL urinary tract infections (ACCEPT—UTI)

Autor: Sylvia S Stefanos, Sami Sakaan, Michael Samarin, Michael S Gelfand, Kerry O Cleveland, Jessie Gant, Sydney Kermeen, Diana A Hobbs, Athena L V Hobbs

Publikováno v: JAC-Antimicrobial Resistance. 5

Background Data are limited regarding use of piperacillin/tazobactam for ESBL urinary tract infections (UTIs). The objective of this study was to compare clinical outcomes of patients treated empirically with piperacillin/tazobactam versus carbapenem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ea011e244708dd0b5fd2194668f1e0d
https://doi.org/10.1093/jacamr/dlad055

Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta-analysis with trial sequential analysis.

Autor: Reynolds PM; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.; Department of Clinical Pharmacy, Denver VA Medical Center, Aurora, Colorado, USA., Stefanos S; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA., MacLaren R; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.

Publikováno v: Pharmacotherapy [Pharmacotherapy] 2023 Feb; Vol. 43 (2), pp. 104-114. Date of Electronic Publication: 2023 Jan 21.